Intestinal biopsies from 80 subjects
450 subjects with CRC-compatible symptomatology
172 FIT + subjects from a screening population
327 FIT + subjects from a screening population
2.800 FIT +/- subjects from a screening population
There is a need for tools able to maintain and restore intestinal balance effectively.
The prebiotic of GoodGut with beneficial properties for intestinal health is a non-digestible fiber that has been developed to induce the selective growth of the protective bacteria and increase their immunoprotective activity, such as the production of volatile fatty acids. In addition, it provides several advantages compared to probiotics:
PREVIPECT has been tested in a pilot study with fecal samples from 18 patients with Inflammatory Bowel Disease, Irritable Bowel Syndrome, and health subjects, studying the effect of the prebiotic on the fecal microbiota, in collaboration with Hospital Universitari de Girona Dr. Josep Trueta. In addition, we completed the In Vitro toxicity test. For more information, you can check the results published in the study here (Oliver L. et al, 2021).
In order to be able to administer the optimal amount to provide the greatest benefit, encapsulation assays will be carried out. With this, we plan to register the product in 2022.